Sign In
Buy PCRX
$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Pfizer (PFE) Receives a Buy from RBC Capital
10:23am, Monday, 27'th Apr 2020
In a report released today,
Randall Stanicky
from RBC Capital maintained a
Buy
rating on Pfizer (
PFE
–
Research Report
), with a price target of
$44.00
. The company’s shares closed last Friday a
Perrigo Company (PRGO) Receives a Buy from RBC Capital
10:23am, Monday, 27'th Apr 2020
RBC Capital analyst Randall Stanicky maintained a Buy rating on Perrigo Company (PRGO) yesterday and set a price target of $58.00. The company's shares
Financial Counselors Inc. Buys 2,160 Shares of Pacira Biosciences Inc (NASDAQ:PCRX)
09:56am, Monday, 27'th Apr 2020
Financial Counselors Inc. boosted its stake in Pacira Biosciences Inc (NASDAQ:PCRX) by 43.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange C
Stifel Nicolaus Remains a Buy on Principia Biopharma (PRNB)
08:07am, Monday, 27'th Apr 2020
In a report issued on April 23, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Principia Biopharma (PRNB). The company's shares closed last
Stifel Nicolaus Remains a Buy on Principia Biopharma (PRNB)
08:07am, Monday, 27'th Apr 2020
In a report issued on April 23, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Principia Biopharma (PRNB
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), AbbVie (ABBV) and Sanofi (OtherSNYNF)
02:43am, Monday, 27'th Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PTC Therapeutics (PTCT), AbbVie (ABBV) and Sanofi
Stocks Showing Improved Relative Strength: Pacira Pharmaceuticals
12:00am, Friday, 24'th Apr 2020Analysts' Top Healthcare Picks: Eagle Pharmaceuticals (EGRX), Biogen (BIIB)
02:41pm, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eagle Pharmaceuticals (EGRX) and Biogen (BIIB) with bullish
Why Pacira BioSciences, Inc.'s (NASDAQ:PCRX) CEO Pay Matters To You
12:59pm, Thursday, 23'rd Apr 2020
In 2007, Dave Stack was appointed CEO of Pacira BioSciences, Inc. (NASDAQ:PCRX). This report will, first, examine the...
Stock Traders Purchase High Volume of Call Options on Pacira Biosciences (NASDAQ:PCRX)
07:52am, Thursday, 23'rd Apr 2020
Pacira Biosciences Inc (NASDAQ:PCRX) was the target of some unusual options trading activity on Tuesday. Stock investors purchased 606 call options on the company. This represents an increase of appro
Pacira Biosciences Inc (NASDAQ:PCRX) Given Consensus Rating of "Buy" by Analysts
06:24am, Thursday, 23'rd Apr 2020
Pacira Biosciences Inc (NASDAQ:PCRX) has been assigned an average recommendation of “Buy” from the eighteen analysts that are currently covering the stock, Marketbeat reports. Seven research analy
Stifel Nicolaus Keeps a Buy Rating on Principia Biopharma (PRNB)
08:00am, Wednesday, 22'nd Apr 2020
Stifel Nicolaus analyst Derek Archila reiterated a Buy rating on Principia Biopharma (PRNB) on April 17. The company's shares closed last Tuesday at
Stifel Nicolaus Keeps a Buy Rating on Principia Biopharma (PRNB)
08:00am, Wednesday, 22'nd Apr 2020
Stifel Nicolaus analyst Derek Archila reiterated a Buy rating on Principia Biopharma (PRNB – Research Report) on April 17. The
Esperion (ESPR) Received its Third Buy in a Row
04:33pm, Monday, 20'th Apr 2020
After Needham and Merrill Lynch gave Esperion (NASDAQ: ESPR) a Buy rating last month, the company received another Buy, this time from Stifel Nicolaus.
Esperion (ESPR) Received its Third Buy in a Row
04:33pm, Monday, 20'th Apr 2020
After Needham and Merrill Lynch gave Esperion (NASDAQ: ESPR) a Buy rating last month, the company received another Buy, this
